公司活动 - 小米正式启动2025年创意竞赛 主题为"你的屏幕 你的故事" 设立三个参赛类别：瞬间定格（壁纸摄影）、智见视界（AI壁纸）和重塑用户体验（主题设计）[1] - 竞赛评审团由全球杰出设计专家组成 参赛者有机会与行业顶尖专家交流 优秀作品将向数百万用户展示[2] - 竞赛设置多项奖励机制 金奖奖金高达10,000美元 获奖作品将获得广泛曝光和潜在商业机会 特别为小米粉丝设立专属奖项[3] - 作品提交于9月10日开始 用户投票9月30日启动 专家评审11月进行 获奖名单将于12月公布[4] 合作伙伴关系 - 竞赛由小米国际互联网业务部与谷歌Gemini联合举办 该部门管理着覆盖100多个市场的国际内容生态系统 包括壁纸、主题、小组件等个性化体验内容[5] - Gemini是谷歌开发的AI助手 旨在提升创造力和生产力 用户可通过实时对话进行头脑风暴、简化复杂话题及重要场景演练[6] - 小米国际互联网业务部期待看到参赛者利用Gemini技术创造惊艳的影像作品 特别是在AI和摄影类别中[6] 生态系统建设 - 小米国际互联网业务部运营着丰富的国际内容生态 涵盖壁纸、主题、小组件等 为全球100多个市场用户提供高度个性化体验[5] - 公司近期与Moloco建立全球战略合作伙伴关系 Moloco是运营机器学习和广告技术领域的领导者 合作旨在推动数百万移动应用的增长[7] - 小米互联网合作伙伴会议（MIPC新加坡2025）于11月27日在新加坡成功举办 汇聚100多家行业领先企业 共同构建可持续的开放生态系统[8]

Accessibility StatementSkip Navigation SAN DIEGO, Sept. 28, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fortinet, Inc. (NASDAQ: FTNT) common stock between November 8, 2024 and August 6, 2025, both dates inclusive (the "Class Period"), have until November 21, 2025 to seek appointment as lead plaintiff of the Fortinet class action lawsuit. Captioned Oklahoma Firefighters Pension and Retirement System v. Fortinet, Inc., No. 25-cv-08037 (N.D. C ...

Accessibility StatementSkip Navigation RADNOR, Pa., Sept. 28, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLPÂ (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Dow Inc. ("Dow") (NYSE: DOW) on behalf of those who purchased or otherwise acquired Dow securities between January 30, 2025, and July 23, 2025, inclusive (the "Class Period"). The lead plaintiff deadline is October 28, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffer ...

Accessibility StatementSkip Navigation RADNOR, Pa., Sept. 28, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Charter Communications, Inc. ("Charter") (NASDAQ: CHTR) on behalf of those who purchased or otherwise acquired Charter securities, including purchasers of call options, or sellers of put options, between July 26, 2024, and July 24, 2025, inclusive (the "Class Period"). The lead pl ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Coherent Corp. ("Coherent" or the "Company") (NYSE: COHR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. Also from this source On this news, Coherent's stock price fell $22.36 per share, or 19.61%, to close at $91.65 per share on August 14, 2025. Pomerantz LLP, with offices in New York, Chicago, Los Angele ...

On March 10, 2025, Cytokinetics disclosed that the U.S. Food and Drug Administration ("FDA") had decided not to convene an advisory committee meeting to review the Company's New Drug Application ("NDA") for aficamten. On May 1, 2025, Cytokinetics announced that the FDA had extended the Prescription Drug User Fee Act action date for aficamten's NDA from September 26, 2025 to December 26, 2025 in order to review a Risk Evaluation and Mitigation Strategy ("REMS") submitted at the FDA's request after the initi ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stride, Inc. ("Stride" or the "Company") (NYSE: LRN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Stride and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the cl ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether DexCom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the ...

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fid ...

NEW YORK , Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Galiano Gold Inc. ("Galiano" or the "Company") (NYSE: GAU). ...